John Wiley & Sons, Inc.
Financials
Valuation Metrics
John Wiley & Sons, Inc.'s Market Cap is $2.63B. At end of 2025 it was $1.60B. Ranked #1797 of 3,116 in US market (top 58%), #1153 of 1,644 on NYSE (top 70%), #45 of 84 in Media & Entertainment (top 54%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.63B | US#1,797/3,116 Sec#45/84 |
| Revenue | $1.67B | US#1,538/3,116 Sec#53/84 |
| Net Income | $198M | US#1,285/3,116 Sec#29/84 |
| Total Assets | $3.13B | US#1,781/3,116 Sec#53/84 |
| Net Assets | $797M | US#1,912/3,116 Sec#48/84 |
| Employees | 5,200 | US#1,206/3,116 Sec#36/84 |
| Value | ||
| P/E | 13.25x | US#617/3,116 Sec#13/84 |
| P/B | 3.29x | US#1,857/3,116 Sec#53/84 |
| PEG | 0.13x | US#232/3,116 Sec#9/84 |
| P/S | 1.58x | US#1,075/3,116 Sec#47/84 |
| EV/EBITDA | 16.78x | US#1,691/3,116 Sec#48/84 |
| FCF Yield | 8.05% | US#828/3,116 Sec#34/84 |
| Profitability | ||
| ROE | 24.87% | US#414/3,116 Sec#13/84 |
| ROA | 6.33% | US#867/3,116 Sec#22/84 |
| Op. Margin | 14.75% | US#1,215/3,116 Sec#26/84 |
| Revenue Growth | -0.27% | US#2,221/3,116 Sec#64/84 |
| Earnings Growth | 103.70% | US#286/3,116 Sec#10/84 |
| Financial Health | ||
| Debt Ratio | 293.00% | US#2,080/3,116 Sec#60/84 |
| Total Debt | $1.37B | US#1,357/3,116 Sec#44/84 |
| FCF | $212M | US#1,351/3,116 Sec#42/84 |
| Cash | $106M | US#2,196/3,116 Sec#71/84 |
| Current Ratio | 0.64x | US#2,638/3,116 Sec#76/84 |
| Net Debt/EBITDA | 5.46x | US#2,080/3,116 Sec#60/84 |
| Dividend | ||
| Div. Yield | 2.80% | US#663/3,116 Sec#14/84 |
| Div. Growth | 0.51% | US#1,184/3,116 Sec#20/84 |
| Performance | ||
| 1Y Return | 40.39% | US#634/3,116 Sec#13/84 |
| 1M Return | 7.73% | US#954/3,116 Sec#21/84 |
| From 52W High | -10.93% | US#881/3,116 Sec#21/84 |
| 1Y MDD | -23.78% | US#887/3,116 Sec#21/84 |
| Trading | ||
| Volume | 230,102 shares | US#2,502/3,116 Sec#75/84 |
| Trading Value | $12M | US#2,142/3,116 Sec#56/84 |
| Per Share | ||
| EPS | $3.86 | US#878/3,116 Sec#13/84 |
| BPS | $15.53 | US#1,487/3,116 Sec#33/84 |
Company Info
John Wiley & Sons, Inc., a publisher, provides authoritative content, data-driven insights, and knowledge services for the advancement of science, innovation, and learning in the United States, China, the United Kingdom, Japan, Australia, and internationally. The company's Research segment provides scientific, technical, medical, and scholarly journals, as well as related content and services in the areas of physical sciences and engineering, health sciences, social sciences, and humanities, and life sciences. This segment sells its products direct to research libraries and library consortia, as well as to researchers and professional society members, and other customers; and through independent subscription agents. The company's Learning segment offers scientific, professional, and education print and digital books; digital courseware to support students and instructors, and assessment services for businesses and professionals. This segment sells its products and services to business and leadership, technology, behavioral health, engineering/architecture, science, and professional education categories through brick-and-mortar and online retailers, wholesalers who supply such bookstores, college bookstores, individual practitioners, corporations, distributor networks, and government agencies. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.